buspirone is a non-sedating, non-habit-forming medication FDA-approved for generalized anxiety disorder. It's chemically unrelated to SSRIs and benzodiazepines and works through serotonin 5-HT1A receptors. Onset is gradual, two to four weeks. It's often chosen for patients who can't tolerate SSRI side effects, who want to avoid sedation, or as an add-on to an SSRI when partial response has been reached.
Buspirone is one of the more underused medications in the anxiety treatment landscape. It isn't a first-line treatment for any anxiety disorder, but it has a specific role that becomes clear in the right clinical situation. Knowing what it does and what it doesn't do helps explain when a clinician reaches for it.
What buspirone is
Buspirone, originally marketed as BuSpar, is a partial agonist at the serotonin 5-HT1A receptor. This is a different mechanism from SSRIs (which block serotonin reuptake) and from benzodiazepines (which enhance GABA signaling). The pharmacology produces a distinctive clinical profile: anxiolytic effects without sedation, without cognitive impairment, without dependence potential, and without significant drug interactions with alcohol.
It's FDA-approved for generalized anxiety disorder. It's also used off-label as an augmentation strategy for partial responders to SSRIs in both anxiety and depression, and occasionally for sexual side effects of SSRIs.
What it feels like
Patients on buspirone rarely describe it as feeling medicated. The more common description is a gradual reduction in baseline anxiety over several weeks, without the activating side effects that some patients experience early on SSRIs and without the sedation of benzodiazepines or hydroxyzine. There's no immediate effect; a single dose of buspirone doesn't produce a felt change the way a benzodiazepine would.
Common side effects are mild and usually settle within the first week: dizziness, mild nausea, headache. Some patients report a transient sensation of restlessness or lightheadedness in the first few days. Unlike most anxiety medications, buspirone doesn't interact meaningfully with alcohol, doesn't produce withdrawal on discontinuation, and isn't classified as a controlled substance.
When it's chosen
A few situations where buspirone often makes sense.
When a patient hasn't tolerated SSRIs. The common SSRI side effects (nausea, sexual side effects, sleep changes, weight changes) are mostly absent with buspirone.
When sedation must be avoided. Patients who drive for work, operate equipment, or whose jobs require sustained alertness sometimes prefer buspirone over benzodiazepines or sedating antihistamines.
When dependence potential matters. Patients with a history of substance use disorder are reasonable candidates for buspirone because it carries no abuse potential.
As augmentation. A patient on an SSRI with partial response sometimes improves further with the addition of buspirone, particularly for residual anxiety symptoms.
In older adults. Buspirone's lack of sedation, anticholinergic effects, and fall risk makes it a reasonable choice in geriatric anxiety where benzodiazepines are generally avoided.
When it tends not to work
Buspirone has weaker evidence for panic disorder, social anxiety disorder, and OCD than for generalized anxiety. It isn't the right choice for an acute crisis because the onset is slow. Patients who have previously been on benzodiazepines often find buspirone disappointing initially because it lacks the felt-immediate-relief that benzodiazepines provide.
Dosing and timeline
Typical dosing starts at 7.5 mg twice daily and is increased over one to two weeks to a target of 15 to 30 mg twice daily, with the maximum FDA-approved dose at 60 mg per day. The therapeutic effect on anxiety usually develops over two to four weeks, similar to SSRIs.
The medication is taken twice or three times daily because of its short half-life. Missing doses produces a gradual reduction in effect rather than acute withdrawal.
External references
The NIMH page on mental health medications includes buspirone in its anxiolytic discussion. For prescribing detail, the DailyMed buspirone label is the authoritative source.
Related: How CBT and SSRIs actually work for anxiety · SNRIs explained · Benzodiazepines for anxiety · Generalized anxiety disorder